Press Releases

February 1, 2022 Lupin and Axantia Enter into a License, Supply and Technology Sharing Agreement for Pegfilgrastim in the Middle East and North Africa

January 27, 2022 Lupin Signs Promotional Agreement with Exeltis on SOLOSEC® expanding access for Adult Women Suffering with Bacterial Vaginosis and Adults with Trichomoniasis

January 19, 2022 Lupin Signs First Partnership Agreement with Foncoo for China

January 7, 2022 Lupin launches Molnupiravir under the brand name Molnulup for the treatment of COVID-19 in adults in India

December 25, 2021 Lupin Receives Approval from U.S. FDA for Sevelamer Carbonate for Oral Suspension

December 24, 2021 Lupin Receives Tentative Approval from U.S. FDA for Azilsartan Medoxomil Tablets

December 14, 2021 Lupin’s Goa Manufacturing Plant Receives EIR from US FDA

December 10, 2021 Lupin Announces the Launch of its Diagnostics Business

December 3, 2021 Lupin and Biomm Enter into a Distribution and Marketing Agreement for Pegfilgrastim in Brazil